CN Patent

CN114341162B — 作为治疗剂的细胞毒素的肽缀合物

Assigned to Cybersa 2 · Expires 2025-10-17 · 1y expired

What this patent protects

本发明涉及例如拓扑异构酶I抑制剂的细胞毒素的肽缀合物，其适用于治疗例如癌症的疾病。

USPTO Abstract

本发明涉及例如拓扑异构酶I抑制剂的细胞毒素的肽缀合物，其适用于治疗例如癌症的疾病。

Drugs covered by this patent

rucaparib-camsylate (RUCAPARIB CAMSYLATE)

Patent Metadata

Patent number: CN114341162B
Jurisdiction: CN
Classification: —
Expires: 2025-10-17
Drug substance claim: No
Drug product claim: No
Assignee: Cybersa 2
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.